Swiss National Bank Has $3.08 Million Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Swiss National Bank raised its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA – Get Rating) by 2.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,900 shares of the company’s stock after acquiring an additional 1,000 shares during the quarter. Swiss National Bank owned approximately 0.19% of Establishment Labs worth $3,079,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Legato Capital Management LLC purchased a new position in Establishment Labs during the 4th quarter valued at about $872,000. Parkman Healthcare Partners LLC purchased a new position in Establishment Labs during the 3rd quarter valued at about $829,000. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Establishment Labs during the 4th quarter valued at about $69,000. Arizona State Retirement System lifted its holdings in shares of Establishment Labs by 4.1% during the 4th quarter. Arizona State Retirement System now owns 5,478 shares of the company’s stock valued at $360,000 after buying an additional 217 shares during the last quarter. Finally, Perceptive Advisors LLC lifted its holdings in shares of Establishment Labs by 42.5% during the 3rd quarter. Perceptive Advisors LLC now owns 578,253 shares of the company’s stock valued at $31,578,000 after buying an additional 172,494 shares during the last quarter. Hedge funds and other institutional investors own 75.26% of the company’s stock.

Establishment Labs Stock Down 0.6 %

ESTA opened at $68.21 on Tuesday. The business has a 50 day moving average price of $70.29 and a 200 day moving average price of $67.64. Establishment Labs Holdings Inc. has a twelve month low of $44.03 and a twelve month high of $79.88. The company has a debt-to-equity ratio of 97.56, a quick ratio of 2.31 and a current ratio of 3.43. The firm has a market cap of $1.76 billion, a P/E ratio of -20.61 and a beta of 1.01.

Establishment Labs (NASDAQ:ESTA – Get Rating) last posted its earnings results on Monday, February 27th. The company reported ($0.55) earnings per share for the quarter, topping the consensus estimate of ($0.71) by $0.16. Establishment Labs had a negative return on equity of 422.08% and a negative net margin of 47.84%. The firm had revenue of $43.81 million during the quarter, compared to analyst estimates of $43.70 million. Research analysts forecast that Establishment Labs Holdings Inc. will post -2.56 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ESTA. BTIG Research lifted their price target on Establishment Labs from $100.00 to $105.00 and gave the company a “buy” rating in a report on Monday, April 17th. Stephens reiterated an “overweight” rating and set a $89.00 price target on shares of Establishment Labs in a report on Friday, April 21st. Finally, Mizuho lifted their price target on Establishment Labs from $95.00 to $110.00 and gave the company a “buy” rating in a report on Friday, April 21st. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, Establishment Labs presently has an average rating of “Moderate Buy” and a consensus price target of $95.20.

Insider Transactions at Establishment Labs

In other news, Director Leslie Gillin sold 3,759 shares of the business’s stock in a transaction that occurred on Wednesday, March 15th. The stock was sold at an average price of $67.62, for a total transaction of $254,183.58. Following the sale, the director now directly owns 3,599 shares in the company, valued at $243,364.38. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 12.64% of the company’s stock.

Establishment Labs Profile

(Get Rating)

Establishment Labs Holdings, Inc is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm’s products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2.